Stryker Craniomaxillofacial
Clinical trials sponsored by Stryker Craniomaxillofacial, explained in plain language.
A division of Stryker focused on surgical products for craniofacial and maxillofacial procedures.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Custom plastic implants for skull and face defects under scrutiny in new study Results expected Nov 2026 (estimated)
-
Custom plastic implants for skull and face defects under scrutiny in new study
Disease control OngoingThis study is checking how safe and effective Stryker's custom-made PEEK implants are for fixing bone and soft tissue problems in the skull and face. About 99 people who need these implants will be followed for up to 24 months after surgery. The main goal is to see how often infe…
Sponsor: Stryker Craniomaxillofacial • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Facial implant device under Post-Market safety review
Disease control OngoingThis study reviews the safety and performance of Stryker's Facial iD Universal Plate Configurator, a device used to fix facial fractures or during reconstructive surgery. Researchers will look at medical records of 726 patients who received the implant to see if unplanned revisio…
Sponsor: Stryker Craniomaxillofacial • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC